These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 33414705)
21. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations. Nguyen P; Derreumaux P Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046 [TBL] [Abstract][Full Text] [Related]
22. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway. Chang YJ; Chen YR FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730 [TBL] [Abstract][Full Text] [Related]
23. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
27. [Enalaprilat Inhibits Zinc-Dependent Oligomerization of Metal-Binding Domain of Amyloid-beta Isoforms and Protects Human Neuroblastoma Cells from Toxic Action of these Isoforms]. Kozin SA; Polshakov VI; Mezentsev YV; Ivanov AS; Zhokhov SS; Yurinskaya MM; Vinokurov MG; Makarov AA; Mitkevich VA Mol Biol (Mosk); 2018; 52(4):683-691. PubMed ID: 30113034 [TBL] [Abstract][Full Text] [Related]
28. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Ono K; Tsuji M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023927 [TBL] [Abstract][Full Text] [Related]
29. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985 [TBL] [Abstract][Full Text] [Related]
30. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062 [TBL] [Abstract][Full Text] [Related]
31. Structural Interaction of Apolipoprotein A-I Mimetic Peptide with Amyloid-β Generates Toxic Hetero-oligomers. Sahoo BR; Bekier ME; Liu Z; Kocman V; Stoddard AK; Anantharamaiah GM; Nowick J; Fierke CA; Wang Y; Ramamoorthy A J Mol Biol; 2020 Feb; 432(4):1020-1034. PubMed ID: 31866295 [TBL] [Abstract][Full Text] [Related]
32. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers. Rana M; Sharma AK Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208 [TBL] [Abstract][Full Text] [Related]
33. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity. Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344 [TBL] [Abstract][Full Text] [Related]
34. A theranostic agent for in vivo near-infrared imaging of β-amyloid species and inhibition of β-amyloid aggregation. Li Y; Xu D; Ho SL; Li HW; Yang R; Wong MS Biomaterials; 2016 Jul; 94():84-92. PubMed ID: 27107167 [TBL] [Abstract][Full Text] [Related]
35. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718 [TBL] [Abstract][Full Text] [Related]
36. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. Thal DR; Walter J; Saido TC; Fändrich M Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025 [TBL] [Abstract][Full Text] [Related]
37. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
38. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate. Yang T; Li S; Xu H; Walsh DM; Selkoe DJ J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038 [TBL] [Abstract][Full Text] [Related]
39. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules. Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094 [TBL] [Abstract][Full Text] [Related]